ALPHATEC HOLDINGS, INC. (ATEC) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 118.66M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $118.66M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $139.91M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $160.81M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $155.74M | (m) | (m) |
| 2025-06-30 | (m) | (m) | $157.06M | (m) | (m) |
| 2025-03-31 | (m) | (m) | $153.24M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $138.84M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $80.98M | (m) | (m) |
| 2024-06-30 | (m) | (m) | $99.83M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $144.09M | (m) | (m) |
| 2023-12-31 | (m) | (m) | $220.97M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $122.53M | (m) | (m) |
| 2023-06-30 | (m) | (m) | $101.02M | (m) | (m) |
| 2023-03-31 | (m) | (m) | $116.70M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $84.70M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $106.11M | (m) | (m) |
| 2022-06-30 | (m) | (m) | $107.47M | (m) | (m) |
| 2022-03-31 | (m) | (m) | $151.81M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $187.25M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $107.77M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $29.05M | (m) | (m) |
| 2017-12-31 | (m) | (m) | $22.47M | (m) | (m) |
| 2016-12-31 | (m) | (m) | $19.59M | (m) | (m) |
| 2016-06-30 | (m) | (m) | $9.32M | (m) | (m) |
| 2016-03-31 | (m) | (m) | $7.76M | (m) | (m) |
| 2015-12-31 | (m) | (m) | $11.23M | (m) | (m) |
| 2015-09-30 | (m) | (m) | $10.50M | (m) | (m) |
| 2015-06-30 | (m) | (m) | $8.90M | (m) | (m) |
| 2015-03-31 | (m) | (m) | $11.40M | (m) | (m) |
| 2014-12-31 | (m) | (m) | $19.73M | (m) | (m) |
| 2014-09-30 | (m) | (m) | $20.17M | (m) | (m) |
| 2014-06-30 | (m) | (m) | $18.98M | (m) | (m) |
| 2014-03-31 | (m) | (m) | $23.76M | (m) | (m) |
| 2013-12-31 | (m) | (m) | $21.34M | (m) | (m) |
| 2013-09-30 | (m) | (m) | $18.65M | (m) | (m) |
| 2013-06-30 | (m) | (m) | $12.95M | (m) | (m) |
| 2013-03-31 | (m) | (m) | $19.29M | (m) | (m) |
| 2012-12-31 | (m) | (m) | $22.24M | (m) | (m) |
| 2012-09-30 | (m) | (m) | $25.94M | (m) | (m) |
| 2012-06-30 | (m) | (m) | $22.02M | (m) | (m) |
| 2012-03-31 | (m) | (m) | $16.86M | (m) | (m) |
| 2011-12-31 | (m) | (m) | $20.67M | (m) | (m) |
| 2011-09-30 | (m) | (m) | $22.14M | (m) | (m) |
| 2011-06-30 | (m) | (m) | $21.76M | (m) | (m) |
| 2011-03-31 | (m) | (m) | $21.48M | (m) | (m) |
| 2010-12-31 | (m) | (m) | $23.17M | (m) | (m) |
| 2010-09-30 | (m) | (m) | $28.85M | (m) | (m) |
| 2010-06-30 | (m) | (m) | $38.41M | (m) | (m) |
| 2009-12-31 | (m) | (m) | $10.09M | (m) | (m) |
| 2008-12-31 | (m) | (m) | $18.32M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |